Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Wolters Kluwer
  6. News
  7. Summary
    WKL   NL0000395903

WOLTERS KLUWER

(WKL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

WOLTERS KLUWER : > Wolters Kluwer Health Introduces OvidOpenAccess to Support the Research Needs of the Global Medical Community

08/17/2012 | 04:59am EST
Wolters Kluwer Health Introduces OvidOpenAccess to Support the Research Needs of the Global Medical Community Thousands of Open Access Resources from Medknow and PMC Now Integrated within the OvidSP Research Platform

Page Content

New York, NY  (August  16, 2012) - In a commitment to support the research needs of its global medical community, Wolters Kluwer Health today announced the release of OvidOpenAccess, a new search discovery feature that integrates thousands of Open Access (OA) resources within the OvidSP platform. Now OvidSP users can conduct a single search query to uncover relevant answers to important medical questions across subscribed and OA content.

Resources provided through OvidOpenAccess includes more than 200 journals from Medknow, a leading, global Open Access publisher and part of Wolters Kluwer Health, and thousands of OA articles available in PMC (formerly known as PubMed Central), the digital archive of biomedical and life sciences journal literature from the US National Institutes of Health's National Library of Medicine (NLM). OvidOpenAccess is value-added content for all institutional subscribers of the OvidSP platform, the world's leading medical research platform.

 "OvidOpenAccess signals an exciting evolution in our efforts to simplify and speed access to the research, bringing users unrestricted access to peer-reviewed, evidence-based literature made easy in a single search," said Karen Abramson, President and CEO, Wolters Kluwer Health Medical Research. "With the rate of research growth in emerging economies, we're also pleased to bring to the forefront trusted medical content from Medknow that offers users a greater international, transcultural perspective on timely, medical topics."

With OvidOpenAccess, OA content is listed in a separate, easily identifiable results widget alongside the main Search Results pane in OvidSP Basic Search. Users can conduct post search tasks, such as print, save, and export to a project or project folder in the My Projects function. Currently, OvidOpenAccess includes a growing list of more than 70,000 full text articles from Medknow's clinical and research journals. Medknow journals are published on behalf of nearly 160 professional healthcare societies and associations and span a wide range of medical and healthcare disciplines, including nursing pharmacology, and alternative medicine. In addition, users have access, through the PMC Open Access Subset, to bibliographic citations of articles published in more than 1,000 unembargoed journals.

The OvidSP medical research platform delivers a solution of aggregated premium content from more than 150 information producers, and rich search functionality and tools to quickly find and manage search results. Used by more than 12,500 institutions globally, OvidSP helps physicians, clinicians, students, researchers, and librarians to make important decisions to improve patient care, enhance ongoing research, and fuel new discoveries.

About Wolters Kluwer Health
Wolters Kluwer Health (Philadelphia, PA) is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health's customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy.Lippincott Williams & Wilkins, Ovid®, Medknow, UpToDate®, Medi-Span®, Facts & Comparisons®, Pharmacy OneSource®, Lexicomp® and ProVation® Medical.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer has 2011 annual revenues of €3.4 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.

Boiler Plate Content

Contact
Robert Dekker
Vice President, Communications
Wolters Kluwer Health
+1 (215) 521-8928
robert.dekker@wolterskluwer.com


distributed by

ę Publicnow 2012
All news about WOLTERS KLUWER
12/02MEDIA ALERT – As non-fungible tokens (NFTs) gain momentum, taxpayers should be aw..
BU
12/02Share Buyback Transaction Details November 25 – December 1, 2021
AQ
12/01Wolters Kluwer to host virtual CCH« Innovations Conference focused on the trends and te..
BU
12/01Wolters Kluwer completes divestment U.S. legal education business
AQ
12/01Wolters Kluwer N.V. announces an Equity Buyback for ?60 million worth of its shares.
CI
12/01Wolters Kluwer N.V. authorizes a Buyback Plan.
CI
11/30Phoebe Targets Improved Patient Management With Earlier Sepsis Recognition and Interven..
BU
11/29Wolters Kluwer CT Corporation Podcast Weighs the Pros and Cons of S Corporation Status
BU
11/25WOLTERS KLUWER : N.V., - Share Buyback Transaction Details November 18 – November 24..
PU
11/25Share Buyback Transaction Details November 18 – November 24, 2021
AQ
More news
Analyst Recommendations on WOLTERS KLUWER
More recommendations
Financials
Sales 2021 4 720 M 5 340 M 5 340 M
Net income 2021 727 M 822 M 822 M
Net Debt 2021 2 161 M 2 445 M 2 445 M
P/E ratio 2021 35,0x
Yield 2021 1,46%
Capitalization 25 645 M 28 948 M 29 012 M
EV / Sales 2021 5,89x
EV / Sales 2022 5,60x
Nbr of Employees 18 670
Free-Float 96,1%
Chart WOLTERS KLUWER
Duration : Period :
Wolters Kluwer Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WOLTERS KLUWER
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 98,80 €
Average target price 89,27 €
Spread / Average Target -9,65%
EPS Revisions
Managers and Directors
Nancy McKinstry Chairman-Executive Board & Chief Executive Officer
Kevin B. Entricken Chief Financial Officer
Frans J. G. M. Cremers Chairman-Supervisory Board
Jeanette Horan Independent Member-Supervisory Board
Ann Elizabeth Ziegler Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
WOLTERS KLUWER42.54%28 948
S&P GLOBAL INC.36.60%109 796
RELX PLC30.77%59 771
THOMSON REUTERS CORPORATION48.41%58 082
MSCI INC.35.14%49 752
EQUIFAX INC.46.49%34 465